Our blog
REMAP-CAP update
The team at Spiral are working many hours to adapt our platform for the COVID-19 Pandemic. One of our projects is in the unique position of enrolling patients with COVID-19 and allocating them to one [...]
Coronavirus and how we play the adaptation game
We are busy adapting one of our biggest projects to collect data and eventually provide feedback on the best treatment for the novel coronavirus outbreak COVID-19. Coronavirus mutated (or adapted) recently to give us SARS-CoV-2 [...]
The largest ever cardiac arrest trial performed in an ICU setting uses Spinnaker in novel ways!
January 2020 saw the last patient enrolled in the TTM2 Trial. Congratulations TTM2 - the largest ever cardiac arrest trial performed in an ICU setting! The trial has been using our Spinnaker Platform in a [...]
REACTOR Published
The Randomised evaluation of active control of temperature versus ordinary temperature management (REACTOR) trial was published inn October 2019. The published article can be read on the Research Gate Website »
CAMERA2 Results Presented
The Combination Therapy for MRSA Bacteremia Effective but Linked to Higher Mortality, AKI Rates Study (CAMERA2) was presented at ECCMID 2019. You can read more about the study on Contagion Live »
Novel START Published
The Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma Study (Novel-START) was published in the NEJM on the 23rd of May 2019. You can read the full article on the NEJM website (no subscription [...]